Christopher Ehly
Family Medicine · Prairie Village, KSNPI 1346318417
Payments from drug & device makers
Across 382 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$857
- Novo Nordisk$842
- Amgen$403
- Pfizer$398
- Boehringer Ingelheim$255
- plus $2K from 34 others
What the payments were for
- Food & beverage$6,26799%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,306 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 49 | $53,158 |
| MounjaroTirzepatide | 38 | $42,921 |
| EliquisApixaban | 23 | $20,647 |
| TrulicityDulaglutide | 15 | $20,242 |
| XareltoRivaroxaban | 12 | $15,594 |
| OzempicSemaglutide | 15 | $15,323 |
| FarxigaDapagliflozin Propanediol | 18 | $14,718 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $14,509 |
| MyrbetriqMirabegron | 27 | $12,456 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $8,183 |
| Repatha SyringeEvolocumab | 12 | $6,309 |
| Leucovorin Calcium | 11 | $3,067 |
| Rosuvastatin Calcium | 191 | $2,105 |
| SynthroidLevothyroxine Sodium | 22 | $1,730 |
| Ezetimibe | 52 | $1,691 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $857 | $63,16353 claims |
| Boehringer IngelheimJardiance | $255 | $53,15849 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $71 | $22,69328 claims |
| PfizerEliquis, Paxlovid | $398 | $22,07637 claims |
| Johnson & JohnsonXarelto | $109 | $15,59412 claims |
| Novo NordiskOzempic | $842 | $15,32315 claims |
| AstraZenecaFarxiga | $241 | $14,71818 claims |
| Astellas Pharma US IncMyrbetriq | $39 | $12,45627 claims |
| AbbVieSynthroid | $1,220 | $1,73022 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $50 | $74578 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Prairie Village
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.